Search

for
Search:

Research

5 / 327 results

research Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study

July 2023 in “SKIN The Journal of Cutaneous Medicine”

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

research Sustained hair regrowth with ritlecitinib to Week 48 in patients with alopecia areata: post hoc analysis of the ALLEGRO phase 2b/3 study

March 2023 in “SKIN The Journal of Cutaneous Medicine”

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

research 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study

1 citations , September 2023 in “Journal of the American Academy of Dermatology”

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

research 42005 Sustained scalp, eyebrow, and eyelash hair regrowth with ritlecitinib through Week 48 in patients with alopecia areata: post hoc analysis of the ALLEGRO phase 2b/3 study

1 citations , September 2023 in “Journal of the American Academy of Dermatology”

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

research Sustained Scalp, Eyebrow, and Eyelash Hair Regrowth with Ritlecitinib Through Week 48 in Patients with Alopecia Areata: Post-Hoc Analysis of the ALLEGRO Phase 2b/3 Study

November 2023 in “SKIN The Journal of Cutaneous Medicine”

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

View more "allegro phase 2b 3 study" in research →

Community Join

3 / 1000+ results

community Pelage have presented only phase 2a. The rest of phase 2 for PP405 will be presented at a later medical meeting

in Chat 30 upvotes 3 months ago

PP405's phase 2a trial results were presented, focusing on safety and pharmacokinetics, with a future meeting planned to share the full dataset. The trial includes a randomized controlled portion and an open-label extension, with no indication of phase 2B completion.

community Trial for TDM-105795 update from research office

in Research/Science 17 upvotes 2 years ago

The trial for TDM-105795 has been completed, and it was in phase 2A. The discussion seeks input on the next phases, 2B or 3, based on safety and efficacy.

community Are we still getting the PP405 phase 2a results by the end of March?

in Research/Science 27 upvotes 4 months ago

People are discussing the anticipated release of PP405 phase 2a results, expected by the end of March, with some skepticism about its effectiveness. There is cautious optimism due to past experiences with similar treatments like Breezula, despite concerns about the lack of presentation at the AAD 2026 conference.

View more "allegro phase 2b 3 study" in community →

Clinics

6 / 17 results

All 17 clinic results →

Experts

6 / 6 results

Learn

— no results

Try a deeper search in learn →